NCT06689995View on ClinicalTrials.gov

A Clinical Study to Determine the Safety and Efficacy of an Oral Supplementation of Bio-Immune®for Managing Upper Respiratory Tract Infection and Its Symptoms.

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

December 30, 2024

Primary Completion Date

January 29, 2025

Study Completion Date

January 29, 2025

Conditions
Upper Respiratory Tract Infection
Interventions
OTHER

Bio-immune Capsule

Dosage Form: Capsule Route of administration: Oral Frequency: 1 capsule, twice a day after meal for 5 days Dose: 100 mg

OTHER

Placebo

Dosage Form: Capsule Route of administration: Oral Frequency: 1 capsule, twice a day after meal for 5 days

Trial Locations (1)

382481

NovoBliss Research Pvt.Ltd, Ahmedabad

All Listed Sponsors
collaborator

Ambe Phytoextracts Pvt. Ltd

INDUSTRY

lead

NovoBliss Research Pvt Ltd

OTHER

NCT06689995 - A Clinical Study to Determine the Safety and Efficacy of an Oral Supplementation of Bio-Immune®for Managing Upper Respiratory Tract Infection and Its Symptoms. | Biotech Hunter | Biotech Hunter